ATE414780T1 - Methoden für gentransfer mit retroviren - Google Patents

Methoden für gentransfer mit retroviren

Info

Publication number
ATE414780T1
ATE414780T1 AT03016618T AT03016618T ATE414780T1 AT E414780 T1 ATE414780 T1 AT E414780T1 AT 03016618 T AT03016618 T AT 03016618T AT 03016618 T AT03016618 T AT 03016618T AT E414780 T1 ATE414780 T1 AT E414780T1
Authority
AT
Austria
Prior art keywords
target cells
binding
retroviruses
gene transfer
methods
Prior art date
Application number
AT03016618T
Other languages
English (en)
Inventor
Mitsuhiro Ueno
Hirofumi Yoshioka
Haruko Konishi
Kimikazu Hashino
Mio Morishita
Hideto Chono
Tsuyoshi Miyamura
Mutsumi Sano
Kiyozo Asada
Kei Fujinaga
Ikunoshin Kato
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Application granted granted Critical
Publication of ATE414780T1 publication Critical patent/ATE414780T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13045Special targeting system for viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00Vectors comprising a targeting moiety
    • C12N2810/10Vectors comprising a non-peptidic targeting moiety
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00Vectors comprising a targeting moiety
    • C12N2810/50Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00Vectors comprising a targeting moiety
    • C12N2810/50Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/851Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from growth factors; from growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00Vectors comprising a targeting moiety
    • C12N2810/50Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/859Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT03016618T 1998-07-01 1999-06-25 Methoden für gentransfer mit retroviren ATE414780T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18624098 1998-07-01
JP5691599 1999-03-04

Publications (1)

Publication Number Publication Date
ATE414780T1 true ATE414780T1 (de) 2008-12-15

Family

ID=26397921

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03016618T ATE414780T1 (de) 1998-07-01 1999-06-25 Methoden für gentransfer mit retroviren
AT99926821T ATE350482T1 (de) 1998-07-01 1999-06-25 Gentransfermethoden

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT99926821T ATE350482T1 (de) 1998-07-01 1999-06-25 Gentransfermethoden

Country Status (10)

Country Link
US (3) US6787359B1 (de)
EP (2) EP1362918B8 (de)
JP (1) JP3807937B2 (de)
KR (1) KR100608154B1 (de)
CN (1) CN1190496C (de)
AT (2) ATE414780T1 (de)
AU (1) AU4393899A (de)
DE (2) DE69939955D1 (de)
ES (2) ES2277438T3 (de)
WO (1) WO2000001836A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551843B1 (en) * 1999-01-29 2003-04-22 Immunivest Corporation Methods for enhancing binding interactions between members of specific binding pairs
CN1225285C (zh) * 1999-03-23 2005-11-02 宝生物工程株式会社 基因治疗剂
JP2005052001A (ja) * 2001-07-05 2005-03-03 Takara Bio Inc 遺伝子治療剤
US20100144038A1 (en) * 2003-03-04 2010-06-10 Masato Miyake Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell
JPWO2005001090A1 (ja) * 2003-06-26 2006-07-27 独立行政法人産業技術総合研究所 細胞の核酸導入効率を改善する方法および組成物
EP1715052A4 (de) * 2004-01-29 2007-10-03 Nat Inst Of Advanced Ind Scien Zusammensetzung und verfahren zur erhöhung der gentransfereffizienz
KR101086822B1 (ko) * 2004-09-29 2011-11-25 다카라 바이오 가부시키가이샤 레트로바이러스 벡터 생산용 세포
US20090011485A1 (en) * 2005-02-07 2009-01-08 Takara Bio Inc. Method of retrovirus storage
EP1892294A4 (de) * 2005-06-15 2010-04-14 Takara Bio Inc Verfahren zum transfer von genen in fettzellen oder vorläuferfettzellen
JP5453629B2 (ja) 2006-08-23 2014-03-26 タカラバイオ株式会社 遠心用袋状容器を使用した遺伝子導入方法
TWI456062B (zh) 2006-09-13 2014-10-11 Abbvie Inc 細胞培養改良
EP2295538B1 (de) * 2008-07-07 2015-10-21 Takara Bio Inc. Verfahren zur herstellung einer pluripotenten stammzelle
WO2011024791A1 (ja) 2009-08-25 2011-03-03 タカラバイオ株式会社 レチノイン酸存在下でのt細胞集団の製造方法
WO2012002452A1 (ja) * 2010-06-30 2012-01-05 タカラバイオ株式会社 遺伝子導入方法
US9228206B2 (en) 2010-06-30 2016-01-05 Takara Bio Inc. Method for gene transfer
US9102943B2 (en) 2010-10-05 2015-08-11 Takara Bio Inc. Method for producing virus vector
WO2013051718A1 (ja) 2011-10-07 2013-04-11 国立大学法人三重大学 キメラ抗原受容体
US9399780B2 (en) 2012-03-22 2016-07-26 Takara Bio Inc. Method for producing viral vector
WO2017024318A1 (en) 2015-08-06 2017-02-09 Dana-Farber Cancer Institute, Inc. Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
US11052111B2 (en) 2015-12-08 2021-07-06 Chimera Bioengineering, Inc. Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses
EP4342978A3 (de) 2016-09-01 2024-07-03 Chimera Bioengineering Inc. Goldoptimierte car-t-zellen
US11524988B2 (en) * 2016-09-19 2022-12-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Artificial antigen presenting cells for genetic engineering of immune cells
EP3580212A4 (de) 2017-02-08 2021-03-17 Dana Farber Cancer Institute, Inc. Regulierung von chimären antigenrezeptoren
WO2018156735A1 (en) 2017-02-22 2018-08-30 H. Lee Moffitt Cancer Center And Research Institute, Inc. Bispecific antibody for cancer immunotherapy
JP7717611B2 (ja) 2019-10-11 2025-08-04 タカラバイオ株式会社 siRNA発現ベクター

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014294D0 (en) * 1990-06-27 1990-08-15 Medical Res Council Assay for cytotoxic t cells
JPH05252941A (ja) 1991-08-12 1993-10-05 Sakai Enetsukusu Kk 動物細胞培養用担体
NL9101680A (nl) * 1991-10-04 1993-05-03 Tno Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren.
US5656456A (en) * 1992-07-13 1997-08-12 Bionebraska, Inc. Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof
EP0672129A4 (de) * 1992-11-20 1997-06-11 Univ New Jersey Med Zelltyp spezifischer gentransfer mit hilfe von retroviralen vektoren welche antikörper-hülle fusionsproteine haben.
US6013628A (en) * 1994-02-28 2000-01-11 Regents Of The University Of Minnesota Method for treating conditions of the eye using polypeptides
US5686278A (en) 1994-03-25 1997-11-11 Indiana University Foundation Methods for enhanced retrovirus-mediated gene transfer
JPH08317785A (ja) * 1995-03-17 1996-12-03 Kanagawa Kagaku Gijutsu Akad 糖鎖の固定化法及びそれを用いた細胞培養基材
EP0844004B1 (de) 1995-07-03 2007-09-12 Koken Co., Ltd. Atelocollagen enthaltende gen-zusammensetzungen
JP3867160B2 (ja) * 1995-07-03 2007-01-10 大日本住友製薬株式会社 遺伝子製剤
JP4365456B2 (ja) 1995-09-29 2009-11-18 インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション ウイルス及び細胞結合部位を持つ分子を用いたウイルス媒介性dna導入を増強する方法
EA004928B1 (ru) * 1995-11-13 2004-10-28 Такара Сузо Ко., Лтд Полипептиды, повышающие эффективность генного переноса в клетки-мишени с помощью ретровируса, и гены, их кодирующие
US6133030A (en) * 1997-05-14 2000-10-17 The General Hospital Corporation Co-cultivation of cells in a micropatterned configuration

Also Published As

Publication number Publication date
DE69939955D1 (de) 2009-01-02
EP1094114A1 (de) 2001-04-25
EP1362918A1 (de) 2003-11-19
US20080044903A1 (en) 2008-02-21
ES2316675T3 (es) 2009-04-16
DE69934690T2 (de) 2007-11-15
EP1362918B8 (de) 2009-08-05
KR20010071422A (ko) 2001-07-28
ES2277438T3 (es) 2007-07-01
EP1094114A4 (de) 2002-10-30
ATE350482T1 (de) 2007-01-15
US20040058447A1 (en) 2004-03-25
CN1314947A (zh) 2001-09-26
CN1190496C (zh) 2005-02-23
JP3807937B2 (ja) 2006-08-09
KR100608154B1 (ko) 2006-08-04
WO2000001836A1 (en) 2000-01-13
AU4393899A (en) 2000-01-24
US6787359B1 (en) 2004-09-07
EP1362918B1 (de) 2008-11-19
DE69934690D1 (de) 2007-02-15
EP1094114B1 (de) 2007-01-03

Similar Documents

Publication Publication Date Title
ATE414780T1 (de) Methoden für gentransfer mit retroviren
DE69812420D1 (de) Enzymatische herstellung von homogentisinsäure
DE60034566D1 (de) Peptidakzeptor ligationsverfahren
DK1923471T3 (da) Detektion af nukleinsyrereaktioner på bead-arrays
WO1999005315A3 (en) Nucleic acid sequence analysis
EP1034302A4 (de) De novo oder "universaler" sequenzierungs-array
RU99114859A (ru) Новая альфа-субъединица бета 2-интегрина человека
NZ514347A (en) Polynucleotide sequencing detecting the interaction between the polynucleotide and a helicase / primase enzyme by measuring radiation
ATE454442T1 (de) Kontinuierliche fermentation
DE60043944D1 (de) Zytokin zcyt018
DK0981525T3 (da) (2-(2-Thienyl)-ethylamino)-(2-halophenyl)-acetonitriler som mellemprodukter og fremgangsmåde til deres fremstilling
WO2001044515A3 (en) Apparatus for performing biological reactions
ATE170092T1 (de) Künstliche rezeptoren, antikörper und enzyme
ATE169341T1 (de) Amplifizierter dns-assay
DK0914156T3 (da) Passivt administreret antistof, som forbedrer foderomsætningseffektivitet
ATE240746T1 (de) Immunovektoren zum transport in die zelle und den zellkern
WO2004050857A3 (en) Splice variant of human sodium iii channel (hnaiii18)
EA200100130A1 (ru) Способ выделения гидроксиметилтиобутановой кислоты
ATE110469T1 (de) Nichttrennender festphasen-enzymtest.
AU2001252618A1 (en) Cell proliferation inhibitors
WO2000053616A3 (en) Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage
EP0267521A3 (de) Verfahren zum Nachweis von Nukleinsäure-Hybriden
BR9813347A (pt) Processos altamente seletivo para preparar uma quinonadiimina e para preparar uma quinonadiimina a partir de uma fenilenodiamina correspondente
EP0199261A3 (de) Immunologischer Testkit
RU99111046A (ru) Способ определения функциональной активности компонента c4 комплемента человека

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties